New Life Regenerative Medicine

New Life Regenerative Medicine is a healthcare company focused on providing regenerative biologics derived from human birth tissues, such as the umbilical cord and amniotic membrane. The company's product portfolio includes NewLife-A, NewLife-W, and NewLife-E, which are utilized by clinicians for orthopedic, aesthetic, and wound care treatments. These products are marketed as minimally invasive options to support the body's natural healing processes and manage chronic pain or tissue degradation. New Life operates a nationwide network of partner clinics, providing them with standardized protocols and high-quality tissue allografts. The company emphasizes safety and compliance with FDA regulations regarding Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).